CGH
RXST icon

Crossmark Global Holdings’s RxSight RXST Stock Holding History

Crossmark Global Holdings’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,861
Closed -$473K – 1341
2024
Q2 		$473K Buy
7,861
+242
+3% +$13.8K 0.01% 859
2024
Q1 		$393K Sell
7,619
-5,107
-40% -$251K 0.01% 974
2023
Q4 		$513K Buy
12,726
+357
+3% +$10.5K 0.01% 836
2023
Q3 		$327K Buy
+12,369
New +$369K 0.01% 971

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Crossmark Global Holdings's RXST Position: Q3 2024 in Review

Crossmark Global Holdings sold out of RxSight (RXST) in Q3 2024, closing a stake of 7,861 shares — an estimated $473K sold.

Crossmark Global Holdings first reported a position in RXST in Q3 2023 and held it in 4 quarters. The position peaked at $513K in Q4 2023. 214 funds tracked by Wall St. Rank hold RXST as of Q3 2024.

  • Crossmark Global Holdings reported no remaining RxSight position as of Q3 2024 after selling out during the quarter.
  • Crossmark Global Holdings sold 7,861 RxSight shares in Q3 2024, an estimated $473K.
  • Crossmark Global Holdings first reported a position in RxSight in Q3 2023 and held it in 4 quarters.
  • Crossmark Global Holdings's RxSight position peaked at $513K in Q4 2023.
  • 214 funds tracked by Wall St. Rank held RxSight as of Q3 2024.

Based on Crossmark Global Holdings's 13F filing for Q3 2024, filed 4 Nov 2024.